• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov13
Bioxcel Therap released FY2025 Q3 earnings on November 12 (EST), actual revenue USD 98K (forecast USD 216.67K), actual EPS USD -2.1774 (forecast USD -1.34)
04:00
Bioxcel Therap released FY2025 9 Months Earnings on November 12 (EST), actual revenue USD 386K, actual EPS USD -6.1244
04:00
Oct16
Selvaraju focuses on healthcare stocks such as Bioxcel Therapeutics
13:02
Sep10
BioXcel Therapeutics Announces Positive Results for BXCL501 Phase 3 Trial
10:32
Aug26
BioXcel Therapeutics to Announce Preliminary Results of Serenity Phase 3 Safety Trial
20:01
Aug18
BioXcel Therapeutics Inc. Launches ATM Program to Sell Up to $80 Million in Common Stock
21:16

Schedules & Filings

Schedules
Filings
Nov12
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 98 K, Net Income -30.91 M, EPS -2.1774

Aug12
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 120 K, Net Income -19.19 M, EPS -2.4463

May12
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 168 K, Net Income -7.254 M, EPS -1.5006

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
MSOX
7.940
+107.85%
+4.120
YCBD
1.200
+90.17%
+0.569
THH
15.520
+57.72%
+5.680
WEED
25.325
+55.65%
+9.055
NCI
1.920
+54.84%
+0.680
CNBS
34.820
+54.57%
+12.293
MSOS
5.800
+54.26%
+2.040
CGC
1.740
+53.98%
+0.610
RYM
23.800
+47.73%
+7.690
TLRY
12.150
+44.13%
+3.720
View More